Skip to main content

Advertisement

SpringerLink
Log in

Causes of Death Among Persons Who Survive an Acute Ischemic Stroke

  • Stroke (HP Adams, Section Editor)
  • Published:
Current Neurology and Neuroscience Reports Aims and scope Submit manuscript

Abstract

Stroke and especially its complications are a leading cause of death. Despite reduced morbidity in some developed countries, mortality in stroke patients is still high worldwide. In the past decades, treatment of acute stroke has focused on early intervention, such as revascularization and cerebral edema prevention. However, long-term clinical observations indicate that poststroke pneumonia, cardiovascular complications, and vascular embolism are the major reasons for the increased death rate after stroke. Few evidence-based data are available currently to guide the management of these complications. Thus, systematic studies of these adverse events are essential and urgent to improve survival after stroke.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Johnston KC, Li JY, Lyden PD, Hanson SK, Feasby TE, Adams RJ, et al. Medical and neurological complications of ischemic stroke: experience from the RANTTAS trial. Stroke. 1998;29:447–53.

    CAS  PubMed  Google Scholar 

  2. Hong KS, Kang DW, Koo JS, Yu KH, Han MK, Cho YZ, et al. Impact of neurological and medical complications on 3-month outcomes in acute ischaemic stroke. Eur J Neurol. 2008;15:1324–31.

    PubMed  Google Scholar 

  3. Balami JS, Chen RL, Grunwald IQ, Buchan AM. Neurological complications of acute ischaemic stroke. Lancet Neurol. 2011;10:357–71.

    PubMed  Google Scholar 

  4. Kumar S, Selim MH, Caplan LR. Medical complications after stroke. Lancet Neurol. 2010;9:105–18.

    PubMed  Google Scholar 

  5. Vernino S, Brown Jr RD, Sejvar JJ, Sicks JD, Petty GW, O’Fallon WM. Cause-specific mortality after first cerebral infarction: a population-based study. Stroke. 2003;34:1828–32.

    PubMed  Google Scholar 

  6. Viitanen M, Winblad B, Asplund K. Autopsy-verified causes of death after stroke. Acta Med Scand. 1987;222:401–8.

    CAS  PubMed  Google Scholar 

  7. Dennis MS, Burn JP, Sandercock PA, Bamford JM, Wade DT, Warlow CP. Long-term survival after first-ever stroke: the Oxfordshire Community Stroke Project. Stroke. 1993;24:796–800.

    CAS  PubMed  Google Scholar 

  8. Hankey GJ, Jamrozik K, Broadhurst RJ, Forbes S, Burvill PW, Anderson CS, et al. Five-year survival after first-ever stroke and related prognostic factors in the Perth Community Stroke Study. Stroke. 2000;31:2080–6.

    CAS  PubMed  Google Scholar 

  9. Brønnum-Hansen H, Davidsen M, Thorvaldsen P. Long-term survival and causes of death after stroke. Stroke. 2001;32:2131–6.

    PubMed  Google Scholar 

  10. Hardie K, Hankey GJ, Jamrozik K, Broadhurst RJ, Anderson C. Ten-year survival after first-ever stroke in the Perth Community Stroke Study. Stroke. 2003;34:1842–6.

    PubMed  Google Scholar 

  11. Slot KB, Berge E, Dorman P, Lewis S, Dennis M, Sandercock P. Impact of functional status at six months on long term survival in patients with ischaemic stroke: prospective cohort studies. BMJ. 2008;336:376–9.

    PubMed Central  PubMed  Google Scholar 

  12. Slot KB, Berge E, Sandercock P, Lewis SC, Dorman P, Dennis M. Causes of death by level of dependency at 6 months after ischemic stroke in 3 large cohorts. Stroke. 2009;40:1585–9.

    PubMed  Google Scholar 

  13. Efstathiou SP, Tsioulos DI, Tsiakou AG, Gratsias YE, Pefanis AV, Mountokalakis TD. Plasma adiponectin levels and five-year survival after first-ever ischemic stroke. Stroke. 2005;36:1915–9.

    CAS  PubMed  Google Scholar 

  14. Alberti A, Agnelli G, Caso V, Venti M, Acciarresi M, D’Amore C, et al. Non-neurological complications of acute stroke: frequency and influence on clinical outcome. Intern Emerg Med. 2011;6:S119–23.

    Google Scholar 

  15. Schaller BJ, Graf R, Jacobs AH. Pathophysiological changes of the gastrointestinal tract in ischemic stroke. Am J Gastroenterol. 2006;101:1655–65.

    PubMed  Google Scholar 

  16. Pongmoragot J, Rabinstein AA, Nilanont Y, Swartz RH, Zhou L, Saposnik G. Pulmonary embolism in ischemic stroke: clinical presentation, risk factors, and outcome. J Am Heart Assoc. 2013;2:e000372. Because of limited information currently, this large cohort study evaluated the clinical characteristics, risk factors, and outcomes of PE in patients with acute ischemic stroke. It provides more evidence to show that this serious complication is associated with a higher risk of death and worse disability in stroke patients.

    PubMed Central  PubMed  Google Scholar 

  17. Kallmünzer B, Breuer L, Kahl N, Bobinger T, Raaz-Schrauder D, Huttner HB, et al. Serious cardiac arrhythmias after stroke incidence, time course, and predictors: a systematic, prospective analysis. Stroke. 2012;43:2892–7.

    PubMed  Google Scholar 

  18. Frangiskakis JM, Hravnak M, Crago EA, Tanabe M, Kip KE, Gorcsan J, et al. Ventricular arrhythmia risk after subarachnoid hemorrhage. Neurocrit Care. 2009;10:287–94.

    PubMed Central  PubMed  Google Scholar 

  19. Ay H, Koroshetz WJ, Benner T, Vangel MG, Melinosky C, Arsava EM, et al. Neuroanatomic correlates of stroke-related myocardial injury. Neurology. 2006;66:1325–9.

    CAS  PubMed  Google Scholar 

  20. Elkind MSV. Outcomes after stroke: risk of recurrent ischemic stroke and other events. Am J Med. 2009;122:S7–13.

    PubMed  Google Scholar 

  21. Liao J, O’Donnell MJ, Silver FL, Thiruchelvam D, Saposnik G, Fang J, et al. In-hospital myocardial infarction following acute ischaemic stroke: an observational study. Eur J Neurol. 2009;16:1035–40.

    CAS  PubMed  Google Scholar 

  22. Dhamoon MS, Tai W, Boden-Albala B, Rundek T, Paik MC, Sacco RL, et al. Risk of myocardial infarction or vascular death after first ischemic stroke: the Northern Manhattan Study. Stroke. 2007;38:1752–8.

    PubMed  Google Scholar 

  23. Touze E, Varenne O, Chatellier G, Peyrard S, Rothwell PM, Mas JL. Risk of myocardial infarction and vascular death after transient ischemic attack and ischemic stroke: a systematic review and meta-analysis. Stroke. 2005;36:2748–55.

    PubMed  Google Scholar 

  24. House A, Knapp P, Bamford J, Vail A. Mortality at 12 and 24 months after stroke may be associated with depressive symptoms at 1 month. Stroke. 2001;32:696–701.

    CAS  PubMed  Google Scholar 

  25. Goldhaber SZ. Pulmonary embolism. Lancet. 2004;363:1295–305.

    PubMed  Google Scholar 

  26. CLOTS Trials Collaboration. Effectiveness of thigh-length graduated compression stockings to reduce the risk of deep vein thrombosis after stroke (CLOTS trial 1): a multicentre, randomised controlled trial. Lancet. 2009;373:1958–65.

    Google Scholar 

  27. Kohro S, Yamakage M, Sato K, Sato JI, Namiki A. Intermittent pneumatic foot compression can activate blood fibrinolysis without changes in blood coagulability and platelet activation. Acta Anaesthesiol Scand. 2005;49:660–4.

    CAS  PubMed  Google Scholar 

  28. Thijs V, Lemmens R, Schoofs C, Görner A, Van Damme P, Schrooten M, et al. Microbleeds and the risk of recurrent stroke. Stroke. 2010;41:2005–9.

    PubMed  Google Scholar 

  29. Boulanger JM, Coutts SB, Eliasziw M, Gagnon AJ, Simon JE, Subramaniam S, et al. Cerebral microhemorrhages predict new disabling or fatal strokes in patients with acute ischemic stroke or transient ischemic attack. Stroke. 2006;37:911–4.

    PubMed  Google Scholar 

  30. Imaizumi T, Inamura S, Kohama I, Yoshifuji K, Nomura T, Komatsu K. Nascent lobar microbleeds and stroke recurrences. J Stroke Cerebrovasc Dis. 2014;23:610–7.

    PubMed  Google Scholar 

  31. Imaizumi T, Inamura S, Kohama I, Yoshifuji K, Nomura T, Komatsu K. Nascent deep microbleeds and stroke recurrences. J Stroke Cerebrovasc Dis. 2014;23:520–8.

    PubMed  Google Scholar 

  32. Sen S, Hinderliter A, Sen PK, Simmons J, Beck J, Offenbacher S, et al. Aortic arch atheroma progression and recurrent vascular events in patients with stroke or transient ischemic attack. Circulation. 2007;116:928–35.

    PubMed  Google Scholar 

  33. Lechat PH, Mas JL, Lascault G, Loron PH, Theard M, Klimczac M, et al. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med. 1988;318:1148–52.

    CAS  PubMed  Google Scholar 

  34. Webster MWI, Smith HJ, Sharpe WN, Chancellor AM, Swift DL, Bass NM, et al. Patent foramen ovale in young stroke patients. Lancet. 1988;2:11–2.

    CAS  PubMed  Google Scholar 

  35. Heuschmann PU, Kolominsky-Rabas PL, Misselwitz B, Hermanek P, Leffmann C, Janzen RW, et al. Predictors of in-hospital mortality and attributable risks of death after ischemic stroke: the German Stroke Registers Study Group. Arch Intern Med. 2004;164:1761–8.

    PubMed  Google Scholar 

  36. Katzan IL, Cebul RD, Husak SH, Dawson NV, Baker DW. The effect of pneumonia on mortality among patients hospitalized for acute stroke. Neurology. 2003;60:620–5.

    CAS  PubMed  Google Scholar 

  37. Finlayson O, Kapral M, Hall R, Asllani E, Selchen D, Saposnik G. Risk factors, inpatient care, and outcomes of pneumonia after ischemic stroke. Neurology. 2011;77:1338–45.

    CAS  PubMed  Google Scholar 

  38. Chamorro Á, Meisel A, Planas AM, Urra X, van de Beek D, Veltkamp R. The immunology of acute stroke. Nat Rev Neurol. 2012;8:401–10. This important review suggests an immunologic mechanism in stroke. Chamorro et al. thoroughly illustrate the multifaceted role of the immune system in the pathophysiology of acute stroke, which is significant for future studies.

    CAS  PubMed  Google Scholar 

  39. van de Beek D, Wijdicks EF, Vermeij FH, de Haan RJ, Prins JM, Spanjaard L, et al. Preventive antibiotics for infections in acute stroke: a systematic review and meta-analysis. Arch Neurol. 2009;66:1076–81.

    PubMed  Google Scholar 

  40. Aslanyan S, Weir CJ, Diener HC, Kaste M, Lees KR. Pneumonia and urinary tract infection after acute ischaemic stroke: a tertiary analysis of the GAIN International trial. Eur J Neurol. 2004;11:49–53.

    CAS  PubMed  Google Scholar 

  41. Hilker R, Poetter C, Findeisen N, Sobesky J, Jacobs A, Neveling M, et al. Nosocomial pneumonia after acute stroke: implications for neurological intensive care medicine. Stroke. 2003;34:975–81.

    PubMed  Google Scholar 

  42. Liesz A, Hagmann S, Zschoche C, Adamek J, Zhou W, Sun L, et al. The spectrum of systemic immune alterations after murine focal ischemia: immunodepression versus immunomodulation. Stroke. 2009;40:2849–58.

    CAS  PubMed  Google Scholar 

  43. Prass K, Meisel C, Hoflich C, Braun J, Halle E, Wolf T, et al. Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J Exp Med. 2003;198:725–36.

    CAS  PubMed Central  PubMed  Google Scholar 

  44. Brait VH, Arumugam TV, Drummond GR, Sobey CG. Importance of T lymphocytes in brain injury, immunodeficiency, and recovery after cerebral ischemia. J Cereb Blood Flow Metab. 2012;32:598–611. This novel and important review provides much information about the pathogenic role of T cellss in ischemic stroke based on the current reports. More importantly, it indicates the actions of different T-cell subtypes in stroke-induced immunodeficiency syndrome and ischemic injury. All these are helpful in understanding the mechanism of stroke and planning clinical treatment.

    CAS  PubMed Central  PubMed  Google Scholar 

  45. Saino O, Taguchi A, Nakagomi T, Nakano-Doi A, Kashiwamura S, Doe N, et al. Immunodeficiency reduces neural stem/progenitor cell apoptosis and enhances neurogenesis in the cerebral cortex after stroke. J Neurosci Res. 2010;88:2385–97.

    CAS  PubMed  Google Scholar 

  46. Trakhtenberg EF, Goldberg JL. Neuroimmune communication. Science. 2011;334:47–8.

    CAS  PubMed  Google Scholar 

  47. Hurn PD, Subramanian S, Parker SM, Afentoulis ME, Kaler LJ, Vandenbark AA, et al. T- and B-cell deficient mice with experimental stroke have reduced lesion size and inflammation. J Cereb Blood Flow Metab. 2007;27:1798–805.

    CAS  PubMed Central  PubMed  Google Scholar 

  48. Brait VH, Jackman KA, Walduck AK, Selemidis S, Diep H, Mast AE, et al. Mechanisms contributing to cerebral infarct size after stroke: gender, reperfusion, T lymphocytes, and Nox2-derived superoxide. J Cereb Blood Flow Metab. 2010;30:1306–17.

    CAS  PubMed Central  PubMed  Google Scholar 

  49. Liesz A, Zhou W, Mracsko E, Karcher S, Bauer H, Schwarting S, et al. Inhibition of lymphocyte trafficking shields the brain against deleterious neuroinflammation after stroke. Brain. 2011;134:704–20.

    PubMed  Google Scholar 

  50. Ibañez A, Gleichgerrcht E, Manes F. Clinical effects of insular damage in humans. Brain Struct Funct. 2010;214:397–410.

    PubMed  Google Scholar 

  51. Walter U, Kolbaske S, Patejdl R, Steinhagen V, Abu-Mugheisib M, Grossmann A, et al. Insular stroke is associated with acute sympathetic hyperactivation and immunodepression. Eur J Neurol. 2013;20:153–9. Walter et al. conducted a study in a subcohort of the Predictors of Early Chest Infection in Acute Ischemic Stroke trial and found that insular lesions were associated with immunodeficiency. Large infarctions (more than 33% of MCA area) and insular lesions caused infectious complications, especially chest infections. This evidence supports the idea that damage to a specific region in the brain is associated with stroke-induced infectious complications.

    CAS  PubMed  Google Scholar 

  52. Wong CH, Jenne CN, Lee WY, Léger C, Kubes P. Functional innervation of hepatic iNKT cells is immunosuppressive following stroke. Science. 2011;334:101–5.

    CAS  PubMed  Google Scholar 

  53. Minnerup J, Wersching H, Brokinkel B, Dziewas R, Heuschmann PU, Nabavi DG, et al. The impact of lesion location and lesion size on poststroke infection frequency. J Neurol Neurosurg Psychiatry. 2010;81:198–202.

    PubMed  Google Scholar 

  54. Martino R, Foley N, Bhogal S, Diamant N, Speechley M, Teasell R. Dysphagia after stroke: incidence, diagnosis, and pulmonary complications. Stroke. 2005;36:2756–63.

    PubMed  Google Scholar 

  55. Sellars C, Bowie L, Bagg J, Sweeney MP, Miller H, Tilston J, et al. Risk factors for chest infection in acute stroke: a prospective cohort study. Stroke. 2007;38:2284–91.

    PubMed  Google Scholar 

  56. Hoffmann S, Malzahn U, Harms H, Koennecke HC, Berger K, Kalic M, et al. Development of a clinical score (A2DS2) to predict pneumonia in acute ischemic stroke. Stroke. 2012;43:2617–23.

    PubMed  Google Scholar 

  57. Meisel C, Prass K, Braun J, Victorov I, Wolf T, Megow D, et al. Preventive antibacterial treatment improves the general medical and neurological outcome in a mouse model of stroke. Stroke. 2004;35:2–6.

    CAS  PubMed  Google Scholar 

  58. Chamorro A, Horcajada JP, Obach V, Vargas M, Revilla M, Torres F, et al. The Early Systemic Prophylaxis of Infection After Stroke study: a randomized clinical trial. Stroke. 2005;36:1495–500.

    CAS  PubMed  Google Scholar 

  59. Schäbitz WR. Regulatory T, cells in ischemic stroke helpful or hazardous? Stroke. 2013;44:e84.

    PubMed  Google Scholar 

  60. Prass K, Braun JS, Dirnagl U, Meisel C, Meisel A. Stroke propagates bacterial aspiration to pneumonia in a model of cerebral ischemia. Stroke. 2006;37:2607–12.

    PubMed  Google Scholar 

  61. Micieli G, Cavallini A. The autonomic nervous system and ischemic stroke: a reciprocal interdependence. Clin Auton Res. 2008;18:308–17.

    PubMed  Google Scholar 

  62. Hilz MJ, Moeller S, Akhundova A, Marthol H, Pauli E, De Fina P, et al. High NIHSS values predict impairment of cardiovascular autonomic control. Stroke. 2011;42:1528–33.

    PubMed  Google Scholar 

  63. Nagai M, Hoshide S, Kario K. The insular cortex and cardiovascular system: a new insight into the brain-heart axis. J Am Soc Hypertens. 2010;4:174–82.

    PubMed  Google Scholar 

  64. Varnavas GG, Grand W. The insular cortex: morphological and vascular anatomic characteristics. Neurosurgery. 1999;44:127–36.

    CAS  PubMed  Google Scholar 

  65. Cheung RT, Hachinski V. The insula and cerebrogenic sudden death. Arch Neurol. 2000;57:1685–8.

    CAS  PubMed  Google Scholar 

  66. Abboud H, Berroir S, Labreuche J, Orjuela K, Amarenco P. Insular involvement in brain infarction increases risk for cardiac arrhythmia and death. Ann Neurol. 2006;59:691–9.

    PubMed  Google Scholar 

  67. Colivicchi F, Bassi A, Santini M, Caltagirone C. Prognostic implications of right-sided insular damage, cardiac autonomic derangement, and arrhythmias after ischemic stroke. Stroke. 2005;36:1710–5.

    PubMed  Google Scholar 

  68. Laowattana S, Zeger SL, Lima JA, Goodman SN, Wittstein IS, Oppenheimer SM. Left insular stroke is associated with adverse cardiac outcome. Neurology. 2006;66:477–83.

    CAS  PubMed  Google Scholar 

  69. Sander D, Winbeck K, Klingelhofer J, Etgen T, Conrad B. Prognostic relevance of pathological sympathetic activation after acute thromboembolic stroke. Neurology. 2001;57:833–8.

    CAS  PubMed  Google Scholar 

  70. Min WK, Park KK, Kim YS, Park HC, Kim JY, Park SP, et al. Atherothrombotic middle cerebral artery territory infarction topographic diversity with common occurrence of concomitant small cortical and subcortical infarcts. Stroke. 2000;31:2055–61.

    CAS  PubMed  Google Scholar 

  71. Hilz MJ, Dutsch M, Perrine K, Nelson PK, Rauhut U, Devinsky O. Hemispheric influence on autonomic modulation and baroreflex sensitivity. Ann Neurol. 2001;49:575–84.

    CAS  PubMed  Google Scholar 

  72. Christensen H, Boysen G, Christensen AF, Johannesen HH. Insular lesions, ECG abnormalities, and outcome in acute stroke. J Neurol Neurosurg Psychiatry. 2005;76:269–71.

    CAS  PubMed Central  PubMed  Google Scholar 

  73. Katsanos AH, Korantzopoulos P, Tsivgoulis G, Kyritsis AP, Kosmidou M, Giannopoulos S. Electrocardiographic abnormalities and cardiac arrhythmias in structural brain lesions. Int J Cardiol. 2013;167:328–34.

    PubMed  Google Scholar 

  74. Meyer S, Strittmatter M, Fischer C, Georg T, Schmitz B. Lateralization in autonomic dysfunction in ischemic stroke involving the insular cortex. Neuroreport. 2004;15:357–61.

    CAS  PubMed  Google Scholar 

  75. Sykora M, Diedler J, Rupp A, Turcani P, Steiner T. Impaired baroreceptor reflex sensitivity in acute stroke is associated with insular involvement, but not with carotid atherosclerosis. Stroke. 2009;40:737–42.

    PubMed  Google Scholar 

  76. Robinson TG, Dawson SL, Eames PJ, Panerai RB, Potter JF. Cardiac baroreceptor sensitivity predicts long-term outcome after acute ischemic stroke. Stroke. 2003;34:705–12.

    PubMed  Google Scholar 

  77. McLaren A, Kerr S, Allan L, Steen IN, Ballard C, Allen J, et al. Autonomic function is impaired in elderly stroke survivors. Stroke. 2005;36:1026–30.

    PubMed  Google Scholar 

  78. Dütsch M, Burger M, Dörfler C, Schwab S, Hilz MJ. Cardiovascular autonomic function in poststroke patients. Neurology. 2007;69:2249–55.

    PubMed  Google Scholar 

  79. Ishikawa H, Tajiri N, Vasconcellos J, Kaneko Y, Mimura O, Dezawa M, et al. Ischemic stroke brain sends indirect cell death signals to the heart. Stroke. 2013;44:3175–82.

    PubMed  Google Scholar 

  80. Sykora M, Diedler J, Turcani P, Hacke W, Steiner T. Baroreflex: a new therapeutic target in human stroke? Stroke. 2009;40:e678–82.

    PubMed  Google Scholar 

  81. Hijazi Z, Oldgren J, Andersson U, Connolly SJ, Ezekowitz MD, Hohnloser SH, et al. Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: a Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) substudy. Circulation. 2012;125:1605–16.

    CAS  PubMed  Google Scholar 

  82. Takahashi T, Yücel M, Lorenzetti V, Tanino R, Whittle S, Suzuki M, et al. Volumetric MRI study of the insular cortex in individuals with current and past major depression. J Affect Disord. 2010;121:231–8.

    PubMed  Google Scholar 

  83. Feng W, Hendry RM, Adams RJ. Risk of recurrent stroke, myocardial infarction, or death in hospitalized stroke patients. Neurology. 2010;74:588–93.

    PubMed  Google Scholar 

  84. Mohr JP, Thompson JL, Lazar RM, Levin B, Sacco RL, Furie KL, et al. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med. 2001;345:1444–51.

    CAS  PubMed  Google Scholar 

  85. Harvey RL. Prevention of venous thromboembolism after stroke. Top Stroke Rehabil. 2003;10:61–9.

    PubMed  Google Scholar 

  86. Chen CC, Lee TH, Chung CY, Chang WH, Hong JP, Huang LT, et al. Symptomatic pulmonary embolism among stroke patients in Taiwan: a retrospective cohort study. Top Stroke Rehabil. 2012;19:361–8.

    PubMed  Google Scholar 

  87. Stein PD, Fowler SE, Goodman LR, Gottschalk A, Hales CA, Hull RD, et al. Multidetector computed tomography for acute pulmonary embolism. N Engl J Med. 2006;354:2317–27.

    CAS  PubMed  Google Scholar 

  88. Kamphuisen PW, Agnelli G. What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke? Thromb Res. 2007;119:265–74.

    CAS  PubMed  Google Scholar 

  89. Lederle FA, Zylla D, MacDonald R, Wilt TJ. Venous thromboembolism prophylaxis in hospitalized medical patients and those with stroke: a background review for an American College of Physicians Clinical Practice Guideline. Ann Intern Med. 2011;155:602–15.

    PubMed  Google Scholar 

  90. Naccarato M, Chiodo Grandi F, Dennis M, Sandercock PA. Physical methods for preventing deep vein thrombosis in stroke. Cochrane Database Syst Rev. 2010;(8):CD001922.

  91. Ryglewicz D, Baranska-Gieruszczak M, Czlonkowska A, Lechowicz W, Hier DB. Stroke recurrence among 30 days survivors of ischemic stroke in a prospective community-based study. Neurol Res. 1997;19:377–9.

    CAS  PubMed  Google Scholar 

  92. Brown DL, Lisabeth LD, Roychoudhury C, Ye Y, Morgenstern LB. Recurrent stroke risk is higher than cardiac event risk after initial stroke/transient ischemic attack. Stroke. 2005;36:1285–7.

    PubMed  Google Scholar 

  93. Sacco RL, Diener HC, Yusuf S, Cotton D, Ounpuu S, Lawton WA, et al. Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med. 2008;359:1238–51.

    CAS  PubMed Central  PubMed  Google Scholar 

  94. Dearani JA, Ugurlu BS, Danielson GK, Daly RC, McGregor CG, Mullany CJ, et al. Surgical patent foramen ovale closure for prevention of paradoxical embolism- related cerebrovascular ischemic events. Circulation. 1999;100:II171–5.

    CAS  PubMed  Google Scholar 

  95. Khan AR, Bin Abdulhak AA, Sheikh MA, Khan S, Erwin PJ, Tleyjeh I, et al. Device closure of patent foramen ovale versus medical therapy in cryptogenic stroke: a systematic review and meta-analysis. JACC Cardiovasc Interv. 2013;6:1316–23.

    PubMed  Google Scholar 

  96. Rengifo-Moreno P, Palacios IF, Junpaparp P, Witzke CF, Morris DL, Romero-Corral A. Patent foramen ovale transcatheter closure vs. medical therapy on recurrent vascular events: a systematic review and meta-analysis of randomized controlled trials. Eur Heart J. 2013;34:3342–52.

    PubMed  Google Scholar 

  97. Kent D, Kitsios G, Hill MD, Almekhlafi MA, Wilton SB, Ghali WA. Recurrent cerebral ischemia in medically treated patent foramen ovale: a meta-analysis. Neurology. 2011;77:301–2.

    PubMed  Google Scholar 

  98. Furlan AJ, Reisman M, Massaro J, Mauri L, Adams H, Albers GW, et al. Closure or medical therapy for cryptogenic stroke with patent foramen ovale. N Engl J Med. 2012;366:991–9.

    CAS  PubMed  Google Scholar 

  99. Carroll JD, Saver JL, Thaler DE, Smalling RW, Berry S, MacDonald LA, et al. Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. N Engl J Med. 2013;368:1092–100.

    CAS  PubMed  Google Scholar 

  100. Awadh M, MacDougall N, Santosh C, Teasdale E, Baird T, Muir KW. Early recurrent ischemic stroke complicating intravenous thrombolysis for stroke: incidence and association with atrial fibrillation. Stroke. 2010;41:1990–5.

    PubMed  Google Scholar 

  101. Di Tullio MR, Russo C, Jin Z, Sacco RL, Mohr JP, Homma S. Aortic arch plaques and risk of recurrent stroke and death. Circulation. 2009;119:2376–82.

    PubMed Central  PubMed  Google Scholar 

  102. Weimar C, Benemann J, Michalski D, Müller M, Luckner K, Katsarava Z, et al. Prediction of recurrent stroke and vascular death in patients with transient ischemic attack or nondisabling stroke: a prospective comparison of validated prognostic scores. Stroke. 2010;41:487–93.

    PubMed  Google Scholar 

  103. Weimar C, Diener HC, Alberts MJ, Steg PG, Bhatt DL, Wilson PW, et al. The Essen stroke risk score predicts recurrent cardiovascular events: a validation within the REduction of Atherothrombosis for Continued Health (REACH) registry. Stroke. 2009;40:350–4.

    PubMed  Google Scholar 

  104. Coutts SB, Modi J, Patel SK, Demchuk AM, Goyal M, Hill MD. CT/CT angiography and MRI findings predict recurrent stroke after transient ischemic attack and minor stroke: results of the prospective CATCH study. Stroke. 2012;43:1013–7.

    PubMed  Google Scholar 

  105. Eriksson SE, Olsson JE. Survival and recurrent strokes in patients with different subtypes of stroke: a fourteen-year follow-up study. Cerebrovasc Dis. 2001;12:171–80.

    CAS  PubMed  Google Scholar 

  106. Furie KL, Kasner SE, Adams RJ, Albers GW, Bush RL, Fagan SC, et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42:227–76.

    PubMed  Google Scholar 

  107. Rashid P, Leonardi-Bee J, Bath P. Blood pressure reduction and secondary prevention of stroke and other vascular events: a systematic review. Stroke. 2003;34:2741–8.

    PubMed  Google Scholar 

  108. Ovbiagele B, Diener HC, Yusuf S, Martin RH, Cotton D, Vinisko R, et al. Level of systolic blood pressure within the normal range and risk of recurrent stroke. JAMA. 2011;306:2137–44.

    CAS  PubMed  Google Scholar 

  109. Pezzini A, Del Zotto E, Magoni M, Costa A, Archetti S, Grassi M, et al. Inherited thrombophilic disorders in young adults with ischemic stroke and patent foramen ovale. Stroke. 2003;34:28–33.

    PubMed  Google Scholar 

  110. Kartunnen B, Hiltunen L, Rasi V, Vahtera E, Hillbom M. Factor V Leiden and prothrombin gene mutations may predispose to paradoxical embolism in subjects with patent foramen ovale. Blood Coagul Fibrinolysis. 2003;14:261–8.

    Google Scholar 

  111. Lichy C, Reuner KH, Buggle F, Litfin F, Rickmann H, Kunze A, et al. Prothrombin G20210A mutation, but not factor V Leiden, is a risk factor in patients with persistent foramen ovale and otherwise unexplained cerebral ischemia. Cerebrovasc Dis. 2003;16:83–7.

    CAS  PubMed  Google Scholar 

  112. Alberts MJ. Antithrombotic therapy for secondary stroke prevention. Continuum (Minneap Minn). 2011;17:1255–66.

    Google Scholar 

  113. Weir CJ, Muir SW, Walters MR, Lees KR. Serum urate as an independent predictor of poor outcome and future vascular events after acute stroke. Stroke. 2003;34:1951–6.

    PubMed  Google Scholar 

  114. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD. Third universal definition of myocardial infarction. J Am Coll Cardiol. 2012;60:1581–98.

    PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by National Natural Science Foundation of China grants (no. 81274122, no. 81373510, no. 81173578, no. 81102831, no. 81202507, no. 81373997, no. U0832008, Key Program no. 90713045), the National Key Sci-Tech Major Special Item (no. 2012ZX09301002-004, no. 2012ZX09103101-006), the National 863 Program of China (no. 2012AA020303), PCSIRT (no. IRT1007), the Beijing Natural Science Foundation (no. 7131013), the Research Fund for the Doctoral Program of Higher Education of China (no. 20121106130001), and te Ministry of Science and Technology of the People’s Republic of China (no. 2010DFB32900).

Compliance with Ethics Guidelines

ᅟ

Conflict of Interest

Shuai Zhang, Wen-Bin He, and Nai-Hong Chen declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

  1. The State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Department of Pharmacology, Institute of Materia Medica, and Neuroscience Center, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, China

    Shuai Zhang, Wen-Bin He & Nai-Hong Chen

  2. Shanxi University of Traditional Chinese Medicine, Taiyuan, 030024, China

    Wen-Bin He

Authors
  1. Shuai Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wen-Bin He
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nai-Hong Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nai-Hong Chen.

Additional information

This article is part of the Topical Collection on Stroke

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, S., He, WB. & Chen, NH. Causes of Death Among Persons Who Survive an Acute Ischemic Stroke. Curr Neurol Neurosci Rep 14, 467 (2014). https://doi.org/10.1007/s11910-014-0467-3

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11910-014-0467-3

Keywords

Search

Navigation